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Michael Westphala
Cyclic pseudo-peptides derived from marine metabolites of the genus Lissoclinum bistratum and Lissocli-
num patella have attracted scientific interest in the last two decades. Their structural properties and solu-
tion dynamics have been analyzed in detail, elaborate synthetic procedures for the natural products and
synthetic derivatives developed, the biosynthetic pathways studied and it now is possible to produce them
biosynthetically. Initially, these macrocyclic ligands were studied due to their medicinal and pharma-
ceutical potential – some of the isolated cyclic pseudo-peptides show high cytotoxic and antiviral activity.
A major focus in the last decade has been on their CuII coordination chemistry, as a number of studies
have indicated that dinuclear CuII complexes of cyclic peptides may be involved in the ascidians’ meta-
bolism, and this is the focus of the present review.
1. Introduction
Marine life is remarkably different from its terrestrial counter-
part and it is no surprise that the molecules and metabolites
isolated from marine organisms differ strikingly from those of
terrestrial sources. The interest in molecules from marine
organisms increased considerably in the 1960s, when numer-
ous metabolites were found to have excellent antiviral and
cytotoxic properties.1–6 In just 10 years (between 1977 and
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1987), approximately 2500 molecules were isolated from
marine organisms.7,8 To date the medicinal interest in invert-
ebrates has led to the extraction of approximately 10 000
metabolites many of which show pharmaceutical potential.9–18
Among the particularly well-studied organisms are sea squirts
(ascidians), especially the genera Lissoclinum patella and L. bis-
tratum, which are specifically highlighted in this perspective.
Ascidians are sessile animals and remain firmly attached to
substrates, such as rocks and shells. Their name is derived
from the Greek word askidion, which means “leather bottle” and
describes their physical appearance, a sac-like body structure
with a tough outer “tunic” made of the polysaccharide tunicin
which, compared to other tunicates, leads to a rather rigid
“exoskeleton”.8 The alkaloids, especially cyclic peptides, extrac-
table from L. patella and L. bistratum have attracted scientific
interest for more than two decades, as they provide a wide
range of cyclic peptides, based on unusual amino acids and
with unusual structures and properties.8–16,19
Ascidians harbor an obligate symbiont, Prochloron sp.,
which, it is thought, might produce the cyclic peptides.20,21
Through photosynthesis, Prochloron is an extremely important
nutrient for their hosts.22–24 Oxazoline-, thiazole-, and thiazo-
line-based cyclic pseudo-hepta- and pseudo-octapeptides, e.g.
lissoclinamides,25–29 patellamides,30–32 and ascidiacycl-
amide33,34 can be extracted from L. patella; L. bistratum on the
other hand provides oxazoline-based cyclic pseudo-hexa-
peptides such as westiellamide35,36 and bistratamide A–H
(Scheme 1).17,37–40 In the cyclic peptides, heterocyclic moieties
alternate with D- and L-amino acid residues in the peptide
sequence. The heterocycles are formally the condensation
product of threonine or cysteine residues with the preceding
amide functionality. The lack of imidazole heterocycles in the
cyclic pseudo peptides is presumably due to the fact that di-
aminopropanoic acid, formally the amine analogue of serine,
is not available in the ribosome.41,42 Structurally, the peptides
resemble 21-azacrown-7 and 24-azacrown-8 structures that are
highly preorganized for the coordination of metal ions. The
observation that, despite the biotoxicity of CuII, its con-
centration in the ascidians is roughly 104 times higher than in
the surrounding sea water, has fostered the interest in the
macromolecule’s metal ion, and especially CuII coordination
chemistry.34,43–59
The focus of this perspective is on the CuII coordination
chemistry of the L. patella and L. bistratum cyclic peptides and
a series of synthetic analogues. Structure and dynamics of the
metal-free ligands and their applications are also reviewed.
A summary of the biosynthesis and synthetic approaches
towards cyclic peptide synthesis can be found else-
where.18,21,48,53,56,60–68 Specifically, we will discuss here struc-
tures, dynamics and reactivities of the CuII complexes and
recent developments with respect to the question of what their
biological function might be.
2. Cyclic pseudo-peptides
2.1. Structures and dynamics
Solid state and solution studies of the conformations of azole-
based69 marine cyclic peptides provide valuable insights into
the factors which may affect the reactivities and the biological
functions of these interesting molecules (see Fig. 1 and 2, see
Schemes 1 and 2 for the structural formulae).19,27,70–81 Usually,
all protons of the peptide NH groups point towards the center
of the macrocyclic ring and the peptide carbonyl functions
Lawrence R. Gahan
Lawrence Gahan (born in 1949)
obtained a degree in chemistry
and a PhD from La Trobe Univer-
sity, Melbourne, Australia. After
postdoctoral positions in the
United States and England he
was a research fellow in the
Research School of Chemistry at
the Australian National Univer-
sity, Canberra, Australia, with
Professor Alan Sargeson. Follow-
ing a position at Monash Univer-
sity, Melbourne, he moved to the
University of Queensland in Bris-
bane, Australia, in 1984, where he is currently a Professor of
Chemistry. He is interested in transition metal coordination chem-
istry and bioinorganic chemistry.
Graeme R. Hanson
Graeme Hanson (born in 1955)
obtained a BSc (Hons) degree in
chemistry and a PhD from
La Trobe University, Melbourne,
Australia. Subsequently, he was
a research fellow with Prof. Bert
Vallee at the Center for Biophysi-
cal and Biochemical Sciences
and Medicine, Harvard Univer-
sity and with Professor John
Pilbrow in the Department of
Physics at Monash University.
He moved to The University of
Queensland as a lecturer in
Chemistry and then joined the Centre for Magnetic Resonance,
which has evolved into the Centre for Advanced Imaging. He was
promoted to full Professor in 2003 and is a fellow of the Royal
Australian Chemical Institute. His interests lie in the experimental
and theoretical aspects of EPR spectroscopy and their application
in biological inorganic chemistry.
Perspective Dalton Transactions
1936 | Dalton Trans., 2014, 43, 1935–1956 This journal is © The Royal Society of Chemistry 2014
Pu
bl
ish
ed
 o
n 
30
 O
ct
ob
er
 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f Q
ue
en
sla
nd
 on
 12
/10
/20
15
 02
:38
:30
. 
View Article Online
towards the outside, such that the amino acid side chains
adopt pseudo-axial positions. Residues with identical stereo-
chemistry face to the same side of the macrocycle reference
plane, e.g., all valine residues of the C3-symmetrical westiell-
amide H3wa are in S* configuration and therefore face to one
side (see Fig. 1d).
The heterocyclic moieties of cyclic pseudo-hexapeptides are
almost coplanar in the case of incorporation of azoline rings
(partially reduced azole, one instead of two double bonds in
the heterocycle), e.g. oxazoline or thiazoline, whereas in the
case of azole-containing peptides, the heterocyclic moieties of
the macrocycle are arranged in a cone-like structure (see Fig. 1
and 2).82 The dihedral angle χ[Namide–Cα–Cazole–X] (see Fig. 3
for abbreviations) can be used to express the extent of devi-
ation from planarity (χ = 180° in case of planarity). It has been
shown that χ depends on the azole system and the size of the
amino acid side chains:81 the relative energy as a function of χ
was calculated by approximate density functional theory (DFT)
for the reference system with a chiral amino acid coupled to
an azole moiety. A plot of the calculated energies is given in
Fig. 3. The energy profile reflects the flexibility of the specific
reference systems and reveals possible reasons for different
conformations obtained for the various metal-free macro-
cycles. The energy profiles of the imidazole and oxazole refer-
ence systems with a small side chain (Fig. 3, left) exhibit two
minima between 0° and 200°, i.e. 90° and 150° for imidazole,
and 60° and 170° for oxazole, respectively. The small thiazole
reference system, on the other hand, has three energetically
similar minima at 30°, 80° and 160°, respectively, suggesting
that thiazole-containing macrocycles are more flexible.
The energy profiles change significantly when a sterically
demanding side chain is introduced (Fig. 3, right): the larger
tert-butyl groups increase the activation barrier for the rotation
along the dihedral angle χ, leading to a shift of the minima in
the profile – especially dihedral angles between 120° and 200°
are affected. Each energy profile only has one minimum in the
range of 100° to 150°: 149° for the oxazole-, 129° for the thia-
zole-, and 104° for the imidazole tert-butyl reference systems,
respectively.
The computed preference of the azole systems for different
dihedral angles corresponds to that found in the X-ray struc-
tures of the corresponding cyclic pseudo-hexapeptides
(Fig. 1).35,81 The reason for this difference was shown to be
mainly of electronic origin: the π(Cazole–Nhet) orbital of an imi-
dazole ring is high in energy and, accordingly, preferably inter-
acts with the σ*(Cα–Namide) orbital. The optimum interaction
between these two orbitals is at an angle of 90°, where the σ*
(Cα–Namide) orbital is oriented parallel to the π(Cazole–Nhet)
orbital. In contrast, the σ*(Cazole–Nhet) orbital of an oxazole
ring is of low energy and therefore preferably interacts with the
energetically high σ(Cα–Cβ) and σ(Xα–Hα) orbitals. This inter-
action has its optimum at an angle χ of 180°.81
The arrangement of heterocycles, linked by amides, enables
an intramolecular network of bifurcated H-bonds, reflected in
the average Namide–H⋯Nhet distances of 2.24 Å in the center of
the molecule.83 The planar conformation of the macrocycle is
neither affected by the sign of chirality nor by substituents at
Cα. S*- and R*-amino acid side chains are both directed
pseudo-axially in opposite directions from the reference plane
of the macrocycle.
The 18-membered cyclohexapeptides isolated from L. bistra-
tum have a strong preference for a planar secondary structure,
referred to as triangle conformation, that is adopted indepen-
dently of the degree of saturation of the oxazole or thiazole
rings (azole vs. azoline).83 Intramolecular H-bond networks are
also present in the 21-membered Lissoclinum pseudo-cyclo-
heptapeptides, e.g., the lissoclinamides and cis,cis-ceratospong-
amide, and the 24-membered Lissoclinum pseudo-
cyclooctapeptides, e.g. the patellamides and ascidiacyclamide
(Scheme 1). The cyclic pseudo-octapeptides are built up from
an alternating sequence of Ser-, Thr- or Cys-derived azole
rings, linked by hydrophobic amino acids. All Lissoclinum
pseudo-octapeptides isolated so far have C2- or C1-symmetry.
A substantial increase in flexibility compared to the cyclic
pseudo-hexa- and pseudo-heptapeptides might be expected.
However, analysis of the solid state and solution structures
by X-ray crystallography,27,73,74,84,85 1H-NMR spectro-
scopy,19,33,72,85 DFT calculations74 and molecular mechanics/
Monte Carlo/molecular dynamics-based conformational ana-
lyses27,72 indicated that there are four conformers which we
summarize here in two types of conformations: the “saddle-
shaped”, sometimes also referred to as square, and the twisted
“figure-of-eight” conformation (Fig. 4). NMR studies have
shown that the pseudo-octapeptides adopt identical con-
formations in solution and the solid state.26,33,36,66,72,86 In the
“saddle-shaped” conformation all nitrogen atoms point
towards the inside of the macrocycle, while the “figure-of-
eight” conformation is characterized by intramolecular
H-bonds, N–H⋯OvC and N–H⋯Ooxa (oxazoline ring), that
lead to a rotation of the oxazoline rings such that the Noxa
atoms face the outside of the macrocycle.27 Several reasons for
the different preferences are discussed in the literature. One
explanation is that a C2-symmetric substitution results in a
“saddle-shaped” conformation and, with decreasing symmetry,
the twisted “figure-of-eight” form is preferred.87 Another
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Scheme 1 Structures of selected L. patella and L. bistratum cyclic peptides. a Abbreviations used in the text: patellamide D: H4patD; ascidiacycl-
amide: H4asc; westiellamide: H3wa
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possible explanation is based on the steric hindrance induced
by the β-branched side chains (exclusively Val and Ile in H4asc
and H4patA), and this potentially prevents the hydrophobic col-
lapse of the system to the more compact “figure-of-eight”
structure. More recent investigations have shown that a third
factor, namely the incorporated heterocycles and the stereo-
chemistry at Cα, also have substantial influence on the
adopted conformation.56,66
We have studied the influence of the incorporated hetero-
cycles and the stereochemistry at Cα on the adopted confor-
mation of cyclic pseudo-octapeptides with a series of model
systems and found that the adopted conformation not only
depends on the symmetry but also on the configuration of the
connecting amino acids and the incorporated heterocycles.56,57
The comparison of the macrocycles H4pat
1–3 (Scheme 2) allows
conclusions to be drawn about the correlation of the preferred
solution structure of the metal-free macrocycles, structure and
stability of the CuII complexes and reactivities related to carbo-
nic anhydrase and phosphatase activities (see below).56,57,88–90
Symmetric cyclic pseudo-octapeptides adopt the square
conformation and amino acid residues with identical Cα con-
figuration face the same side of a macrocycle. The influence of
Cα on the shape of the macrocycle is clearly visible upon exam-
ination of the X-ray structures of H4pat
1 and H4pat
2 (Fig. 2e
and f). The dimethylimidazole rings of H4pat
1 are oriented in
a zig-zag fashion while the heterocycles of H4pat
2 adopt a
conical shape. H4pat
3 can adopt two conformations in the
solid state: one is identical to that of H4pat
2, in the other two
trans-disposed oxazole rings are rotated such that their ring
systems are coplanar yet, in contrast to H4patD, all nitrogen
atoms are still oriented towards the center of the macrocycle.
The heterocycles of the natural C2-symmetric peptide H4asc
(Fig. 2a) are folded in zig-zag fashion, comparable to H4pat
1.
Fig. 1 Top (left) and side (right) views of the X-ray structures of the syn-
thetic cyclic pseudo-hexapeptides H3wa
im (a), H3wa
ox (b), H3wa
thi (c),
and the natural system westiellamide H3wa (d).
36,81 Color code: N =
blue, O = red, C = grey, oxazole/oxazoline ring = red, thiazole ring =
ochre, dimethylimidazole ring = blue.
Fig. 2 Sideviews of the X-ray structures of (a) H4asc;
84 (b) H4patD;
27 (c)
H4pat
1;56 (d) H4pat
2;56 and (e) top and (f ) side view of the X-ray structure
of H4pat
3.66 Color code: N = blue, O = red, C = grey, oxazole/-ine ring =
red, thiazole ring = ochre, dimethylimidazole ring = blue. Reproduced
by permission of Wiley-VCH from ref. 57.
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The higher flexibility of the oxazoline rings in comparison
to imidazole (H4pat
1,2) and oxazole (H4pat
3) results in a stron-
ger twist of the heterocycles in H4asc, compared to H4pat
1
(Fig. 2). The figure-of-eight conformation adopted by asym-
metric macrocycles (H4patD, Fig. 2b) demands a higher flexi-
bility of the macrocyclic backbone, as the Noxa nitrogen atoms
face towards the outside of the macrocycle and the thiazole
rings are parallel. The synthetic symmetric macrocycles
H4pat
1–3 and the natural peptide ascidiacyclamide have com-
parable distances of their Nhet atoms but a strikingly different
orientation of the heterocycles. The higher rigidity of the imi-
dazoles of H4pat
1 in combination with an alternating configur-
ation at Cα leads to a somewhat more shielded cavity of H4pat
1,
compared to those of H4asc, H4patD, and H4pat
2,3. H4asc and
H4patD have a stronger twist of the heterocycles which enlarges
the accessibility of the cavity, while the identical configuration
Scheme 2 Structures of the patellamide model systems H4pat
1–5, the ascidiacyclamide analogue H4L
ascA, the partly hydrolyzed model systems
H4patJ
1, H4patJ
2, H4patL, H4patN, and the westiellamide analogues H3wa
het.
Perspective Dalton Transactions
1940 | Dalton Trans., 2014, 43, 1935–1956 This journal is © The Royal Society of Chemistry 2014
Pu
bl
ish
ed
 o
n 
30
 O
ct
ob
er
 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f Q
ue
en
sla
nd
 on
 12
/10
/20
15
 02
:38
:30
. 
View Article Online
at all Cα sites in H4pat
2 and H4pat
3 leads to a shielded and an
unshielded side of the macrocycle.
2.2. Function and applications
The biological function of the cyclic pseudo-octapeptides is
unknown. Due to the significant amount of metal ion accumu-
lation in invertebrates91 – specifically copper in L. patella – and
due to the suitability of the cyclic peptide ligands for CuII (see
below), it might be assumed that the natural function of the
patellamide macrocycles involves CuII coordination, but not
even this is a fact. The cyclic peptides and their CuII complexes
might be cofactors in enzymes43 and assume the typical func-
tions of copper enzymes, i.e. electron transfer and oxygen acti-
vation. Another possible function of the macrocycles is their
involvement in CuII transport, storage or detoxification.43,92
Oxygen activation has been suggested as a possible biological
role,43,91,92 but due to the open coordination sites and rather
low reduction potentials,89 this does not seem to be a probable
role except if the pseudo-peptides are prosthetic groups in
proteins. CO2 hydration (carbonic anhydrase acti-
vity),23,34,43,56,57,90,93,94 and phosphoester hydrolysis (phos-
phatase activity)88 have recently been proposed as possible
biological functions, and this will be discussed in detail below.
Due to the known cytotoxic, antibacterial, antineoplastic
and antiviral activities of the metal-free cyclic pseudo-peptides,
medicinal and pharmaceutical applications have been studied
extensively13,17,18,44,95,96 and still are a driving force for cyclic
peptide chemistry. The cyclic pseudo-peptides’ use as macro-
cyclic ligands in transition metal coordination chemistry has
been another focus of Lissoclinum-derived cyclic peptides, and
Fig. 3 Abbreviations and building blocks of natural and synthetic cyclic peptides used for DFT-based (G03, B3LYP/6-31g**) energy profiles
(adopted from ref. 81) of oxazole, thiazole and imidazole reference systems for cyclic pseudo-peptides in relation to the dihedral angle χ;81,82 left:
small side-chain (iso-propyl); right: bulky side-chain (tert-butyl).
Fig. 4 Conformations of cyclic octapeptides: square/saddle shaped (left) and figure-of-eight (right). Reproduced by permission of Wiley-VCH from ref. 57.
Dalton Transactions Perspective
This journal is © The Royal Society of Chemistry 2014 Dalton Trans., 2014, 43, 1935–1956 | 1941
Pu
bl
ish
ed
 o
n 
30
 O
ct
ob
er
 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f Q
ue
en
sla
nd
 on
 12
/10
/20
15
 02
:38
:30
. 
View Article Online
this will be reviewed in detail in the next section. The hydro-
gen bond donating and accepting properties of the alternating
amide and azole groups makes the macrocycles also suitable
receptors for anions, and this has been studied in some
detail.66,97,98
Lissoclinum-derived and other synthetic cyclic peptides have
been used as platforms for applications in molecular recog-
nition.97,99 Synthetic C2 and C3 symmetric macrocycles (see
Scheme 3) were prepared for the selective coordination of
anions – where significant stabilities and selectivities
were achieved and interpreted on the basis of DFT calcu-
lations,83,98,100 the enantioselective coordination of chiral
organo-ammonium ions with selectivities of up to 87 : 13,101
and as a novel class of C3-symmetric cylindrical and conical
container molecules, based on chiral glutamic acid and lysine-
derived thiazole amino acids (also given in Scheme 3).102
Scheme 3 C3-symmetric container molecules 1, 2;
102 C3-symmetric (3) and C2-symmetric imidazole-based receptors (4, 5) for enantiomeric
recognition of primary ammonium salts.98,101
Perspective Dalton Transactions
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Cyclic pseudo-peptides, in particular the pseudo-hexa-
peptides derived from westiellamide and the C2-symmetrical
derivatives depicted in Scheme 3, have been shown to provide
valuable scaffolds for supramolecular chemistry,99,103 where
exciting developments with novel molecular switches, motors
and devices have emerged.104 Particularly interesting recent
examples based on cyclic peptide scaffolds are those of
unidirectional switches,105 a unidirectional motor,106 a
4-stroke motor,107 and a light-induced chirality switch.108
3. Metal binding to Lissoclinum
peptides and synthetic models
The strong preference for a planar secondary structure of the
patellamide-type pseudo-cyclopeptides and the presence of a
cavity with appropriately placed nitrogen and oxygen donors in
these macrocyclic structures has been noted as an optimal
arrangement for chelation.43,56,57,84,89,92,109 Coupled with this,
the observation of the capacity of L. patella to concentrate a
range of metal ions, including but not limited to CuII, led to
extensive efforts over a considerable period to understand the
role of the cyclic peptides in metal ion complexation and
accumulation. Initial reasons for investigation included the
coordination chemistry of the individual metal ions, under-
standing the electronic structures, stabilities and selectivity
with particular metal ions, and recent efforts have
been directed increasingly towards reactivities to elucidate the
possible biological functions of these peptides and
complexes.34,43–47,49,61,67,94,110–113 There is a distinct difference
between various species with respect to the heterocycles
involved in the cyclic peptides, and this must lead to differ-
ences in the corresponding transition metal coordination
chemistry, specifically also in terms of electronic structures,
stabilities and reactivities and therefore might have some
influence in the biological activity. The L. bistratum derived
macrocycles include oxazoline-based cyclic pseudo-hexa-
peptides (e.g. westiellamide, bistratamide A–H) while those from
L. patella include oxazoline-, thiazole- and thiazoline-based
cyclic pseudo-hepta- and pseudo-octapeptides, (e.g. lissoclin-
amides, patellamides and ascidiacyclamide), see Scheme 1.
3.1. Lissoclinum bistratum derived peptides
Initial studies on the metal ion complexation of westiellamide
reported the formation of an unusual Ag4 cluster complex (see
Fig. 5):47 three of the silver(I) ions are disposed in a pseudo-tri-
gonal arrangement about Ag1 and are sandwiched between
two H3wa macrocycles (westiellamide). The central silver ion
Ag1 is coordinated in a distorted octahedral arrangement by
the carbonyl oxygen atoms of the two H3wa ligands. The usual
conformation of the cyclic pseudo-hexapeptide is strongly
twisted in this silver cluster: in order to coordinate to the
central silver(I) ion Ag1, the carbonyl groups of westiellamide
are rotated towards the inside of the ring, thus flipping the
macrocycle and rotating the amide nitrogens such that they
face the outside of the macrocycle (see above for the relative
stability of the various conformers of the metal-free peptide
ligands).
NMR titrations in [D4]methanol indicated that H3wa is
selective for AgI, i.e. only “weak interactions” were observed
with LiI, NaI, KI, CuI, MgII, CdII, HgII, NiII, CuII, FeII, FeIII, AuIII
and CeIII, while the association constant in the AgI 2 : 1
complex was reported to be >105. Extensive work on the H3wa
n/
CuII system in methanol, also including the synthetic ana-
logues H3wa
im, H3wa
thi and H3wa
ox (see Schemes 1 and 2),
using titrations of ligand solutions with CuII and/or base
(OMe−), vis-NIR, CD, ESI-MS and EPR spectroscopy, spectra
simulations, combined with DFT-based molecular modeling,
and microcalorimetry (ITC), indicated that mono- as well as
dinuclear CuII complexes are formed with stability constants
of approx. 105, i.e. similar to those of the patellamide-type
cyclic pseudo-octapeptides (see Table 1).54,55 The structures of
these complexes depend on the electronic properties and,
specifically also on the flexibilities of the heterocycles, and
yield two structural types each for the mono- and dinuclear
CuII complexes, respectively (see Fig. 6).
The synthetic macrocycles H3wa
im, H3wa
thi and H3wa
ox have
the westiellamide (H3wa) backbone, derived from L-valine
amino acid residues, and differ only in their heterocyclic
donor group, i.e. oxazoline, oxazole, imidazole and thiazole
(see Schemes 1 and 2). Importantly, this leads to differences in
shape and flexibility of the macrocycles (see section on struc-
tures and dynamics of the metal-free cyclic pseudo-peptides),
with the oxazoline-based natural macrocycle westiellamide
H3wa being the most flexible, and this is the reason for the
subtle structural differences of the CuII complexes (see Fig. 6)
and thermodynamic properties (see Table 1).
In the mononuclear complexes of the synthetic ligands,
each CuII is coordinated by three nitrogen atoms of the macro-
cycle and the coordination sphere is completed by solvent
molecules (see Fig. 6).54 Two of the nitrogen donors originate
from azole rings and one from the connecting amide group,
forming the usual Nhet–Namide–Nhet bonding motif. The depro-
tonation is metal ion assisted and takes place at relatively low
pH values – CuII is known to be able to deprotonate amide
nitrogen atoms in oligopeptides at pH ≈ 4–5).114–116 The
protons that are released upon coordination of CuII acidify the
solution, and make the addition of base mandatory in order to
achieve complete complexation. In the natural environment,
Fig. 5 X-ray structure of the Ag4 cluster of westiellamide.
47
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the slight basicity and constant pH of ∼8 of seawater provides
the conditions for coordination of CuII to the Nhet–Namide–Nhet
pocket and supports the assumption that the metabolic role of
the cyclic peptides is related to metal ion coordination, specifi-
cally with CuII. Interestingly, the structure of the mononuclear
H3wa complex is strikingly different. The increased flexibility
of the oxazoline heterocycles allows the third heterocycle also
to be coordinated, leading to a distorted square pyramidal
coordination geometry with a Nhet–Namide–Nhet–Nhet donor set
and an axial MeOH completing the coordination sphere (note
that this follows from a thorough analysis of the EPR spectra
supported by DFT calculations).54 This leads to an increased
stability of the mononuclear structure and largely prevents for-
mation of dinuclear complexes. Two isomers are observed for
these dinuclear compounds (see Fig. 6), and these differ by the
donor set provided for the second CuII center: Nhet–Namide–
OMe− vs. Namide–Nhet–Namide.
For the methylimidazole-based macrocycle H3wa
im the
detailed analysis of the solution structure and electronic pro-
perties of the mono- and dicopper(II) complex was extended
with pulsed electron nuclear double resonance (ENDOR),
hyperfine sublevel correlation resonance (HYSCORE) and mag-
netic circular dichroism spectroscopy (MCD), combined with a
detailed DFT study, involving the careful validation of the
theoretical setup (functional and basis set)59 – the compu-
tation of spin Hamiltonian parameters is notoriously
difficult.117 While the analysis of the ENDOR spectra of
[CuII(H2wa
im)]+ confirmed the bonding motif (Nhet–Namide–
Nhet), the three nitrogen nuclei are magnetically inequivalent.
HYSCORE spectra revealed delocalization of the unpaired
Table 1 Complex stabilities of cyclic peptide ligands with various metal ions
Metal ion Cyclic peptide Method K1 K2 Reference
CuII Patellamide A CD 2.00 × 104 7.76 × 102 44, 113
MS 3.31 × 104 1.00 × 104 44
CuII Patellamide B CD 3.02 × 105 2.29 × 102 113
CuII Patellamide C CD 6.70 × 104 44
MS 6.31 × 104 6.03 × 103 44
CuII Patellamide E CD 1.51 × 104 113
ZnII Ascidiacyclamide NMR, CD 1.00 × 103 113
ZnII Patellamide A CD 3.02 × 104 1.00 × 103 44
MS 2.82 × 103 3.89 × 103 44
ZnII Patellamide B CD 3.02 × 104 1.91 × 101 113
ZnII Patellamide C CD 1.78 × 104 8.13 × 102 44
MS 2.40 × 103 2.57 × 103 44
ZnII Patellamide E CD 7.94 × 104 2.00 × 101 113
CuII Lissoclinamide 9 CD 1.41 × 104 1.26 × 102 45
CuII H4pat
1 ITC 1.71 × 106 a 89
CuII H4pat
2 ITC 4.03 × 104 a 89
CuII H4pat
3 ITC 2.27 × 105 a 89
CuII H4pat
4 ITC 1.43 × 105 a 89
CuII H4pat
5 ITC 1.50 × 105 a 89
CuII H3wa
im ITC 2.03 × 105 0.67 × 105 56
CuII H3wa
ox ITC 3.31 × 105 4.14 × 105 56
CuII H3wa
thi ITC 1.97 × 105 0.50 × 105 56
CaII Ascidiacyclamide NMR 7.94 × 102 76
CaII Patellamide D NMR, CD 7.94 × 102 76
a ITC data indicate cooperative binding of two metal ions,48,53,56,56,57,89,133 and structural studies indicate that this is due to preorganization of
the second coordination site by binding of the first CuII ion to the ligand,56 resulting in one K value for both binding sites.
Fig. 6 Solution structures (DFT combined with EPR spectroscopy) of the CuII complexes of westiellamide-type cyclic pseudo-hexapeptides.54
Reproduced by permission of Wiley-VCH from ref. 54.
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electron onto the remote nitrogen of the imidazole ring. A DFT
comparison of the singly occupied orbital for the CuII com-
plexes of all pseudo-hexapeptide ligands, [CuII(H2wa
im)]+,
[CuII(H2wa
thi)]+, [CuII(H2wa
ox)]+ and [CuII(H2wa)]
+ showed sig-
nificant delocalization of the unpaired electron onto the
heterocyclic ring in all cases.
The stability constants of the mono- and dinuclear CuII
complexes of the westiellamide analogues were determined
using isothermal titration calorimetry (ITC) and computed by
standard fitting procedures.55 It was found that the complexa-
tion behavior of the three synthetic analogues H3wa
im, H3wa
thi
and H3wa
ox was strikingly different from one another (see
Table 1). In contrast to H3wa
im and H3wa
thi, H3wa
ox does not
only form mono- and dinuclear CuII complexes but also a
macrocycle : CuII = 2 : 1 species in a preequilibrium, which
leads to significant differences in the solution chemistry. This
unusual coordination mode was confirmed by NMR, EPR and
ESI-MS experiments (note that similar observations emerge for
the pseudo-octapeptide CuII complexes discussed below; see
Scheme 4 for the corresponding structural model). In this
coordination mode, CuII is not coordinated to the usual Nhet–
Namide–Nhet binding site (see above) but interacts with the
“outside” of the macrocycle via carbonyl oxygen atoms from
the amide groups, with MeOH completing the coordination
sphere. DFT calculations confirm this spectroscopically deter-
mined structure. Computational models also confirm the ITC-
based thermodynamic observation that, for H3wa
ox, the strain
induced to the macrocyclic ligand backbone is larger for the
coordination of the first CuII ion than for the second. The
small conformational change needed for the coordination to
the second CuII ion in H3wa
ox facilitates the formation of
dinuclear complexes. The cooperativity of H3wa
im and H3wa
thi
was also observed in ITC experiments.55
3.2. Lissoclinum Patella derived peptides
3.2.1. Solution equilibria. Families of cyclic peptides were
first isolated from L. patella in the 1980s with a range of com-
pounds being identified and characterized.84,118,119 Apart from
the interesting medicinal properties of the metal-free ligands,
the high concentration of CuII and a range of other metal ions
in ascidians,91 together with the structural similarity of the
cyclic pseudo-peptides to aza-crown ethers, suggested that the
peptides are tailor-made for binding to metal ions,43 although
direct evidence for complex formation was originally not avail-
able.109 The potential for metal ion complexation by a range of
marine metabolites, including those from L. patella was dis-
cussed in a 1993 review.112 However, the limiting factor in
metal ion complexation studies was (and partially still is) the
availability of large enough amounts of the metabolites
(ligands). In addition, an often not unambiguously solved
question is,47,112 whether the biological activity involves metal
ion chelation – what exactly the biological activity is has not
yet been studied in detail.
Initial quantitative investigations of the interactions of
metal ions with a range of patellamides were undertaken
using NMR, EPR, UV-vis-NIR and circular dichroism (CD)
spectroscopy. For many reasons CuII usually was the metal ion
of choice, driven to some extent by the spectroscopic advan-
tages of the d9 electronic configuration but also by the biologi-
cal relevance of the metal ion. In some cases the complexation
behavior with ZnII and other metal ions was also investi-
gated,49,120,121 and the solution coordination chemistry of
patellamides A, B, D and E, ascidiacyclamide and a number of
cyclo-octapeptide analogues with CuII and ZnII was investi-
gated in some detail;45,113,120,122,123 in addition, the interaction
of CaII with ascidiacyclamide and patellamide D was also
reported.76 The potassium complex of a partially hydrolyzed
ascidiacyclamide was structurally characterized (Fig. 7).124 The
binding constants for a series of cyclic peptides from L. patella
and L. bistratum together with synthetic analogues are
assembled in Table 1. The log K1:1 binding constants generally
lie in the range 3.5–5.5 for CuII and ZnII; in some cases two
binding events were observed, the second often at least one
order of magnitude smaller than the first (except in cases
where cooperativity is observed, vide infra). The observed
complex stabilities were taken as support for the suggestion
that the CuII complexes are biologically relevant.120 For reac-
tions with ZnII the anion used and the pH were shown to have
a significant influence on the complexation processes122 – for
CuII this obviously is also the case, see below.
Our main focus in the last decade has been on the CuII
chemistry of synthetic analogues of the naturally occurring
cyclic pseudo-octapeptides patellamide D and ascidiacycl-
amide.125 Our original synthetic strategy involved the cyclization
of the octapeptides with open (“hydrolyzed”) oxazoline hetero-
cycles (ligands patN, patL, patJ1 and patJ2, Scheme 2; the hetero-
cycles of these ligands were not closed so far although this
should be feasible).48,53 These syntheses were quite tedious
and did not yield sufficient quantities of the ligands for com-
prehensive studies of the solution coordination chemistry.
However, based on ESI-MS, electronic (UV-vis-NIR and CD)
and EPR spectroscopy, we have been able to fully characterize
the main mono- and dinuclear species in solution. The stoichi-
ometry generally is well defined by ESI-MS experiments and
supported by CD and/or UV-vis-NIR titrations. The electronic
transition energies have so far mainly been used in conjunc-
tion with qualitative ligand field arguments to support the
structural assignments based on EPR spectroscopy. The experi-
mental spectra, in combination with spectra simulations and
molecular modeling to solve the solution structures of the
weakly dipole–dipole coupled dicopper(II) systems have been
extremely useful for the unambiguous structural characteriz-
ations. This approach uses the simulation of the EPR spectra
with structural parameters (Cu⋯Cu distance and relative
orientation of the two chromophores with respect to each
other) in addition to the spin Hamiltonian parameters of the
two CuII centers.126,127 The structural parameters are also
refined with molecular mechanics based molecular modeling,
and this combination (MM-EPR) permits the unambiguous
determination of the solution structures.128 This method has
been further developed to also include the DFT-based compu-
tation of the spin Hamiltonian parameters (MM-DFT-EPR),129
Dalton Transactions Perspective
This journal is © The Royal Society of Chemistry 2014 Dalton Trans., 2014, 43, 1935–1956 | 1945
Pu
bl
ish
ed
 o
n 
30
 O
ct
ob
er
 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f Q
ue
en
sla
nd
 on
 12
/10
/20
15
 02
:38
:30
. 
View Article Online
S
ch
e
m
e
4
C
u
II
co
m
p
le
xa
ti
o
n
e
q
u
ili
b
ri
a
o
f
H
4
p
at
n
.5
7
Perspective Dalton Transactions
1946 | Dalton Trans., 2014, 43, 1935–1956 This journal is © The Royal Society of Chemistry 2014
Pu
bl
ish
ed
 o
n 
30
 O
ct
ob
er
 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f Q
ue
en
sla
nd
 on
 12
/10
/20
15
 02
:38
:30
. 
View Article Online
and more recently, additional parameters (exchange coupling J
and zero-field splitting D) have also been considered in the
spectral simulations, and their prediction is based on a range
of quantum-chemical methods (see also section on the
westiellamide-based macrocycles above).54,130–132 The solution
structures of the dicopper(II) complexes of patN, patL, patJ1 and
patJ2 were solved by MM-EPR,48,53 that of patN together with
the experimental and simulated EPR spectrum are shown in
Fig. 8. At the time this was the second structure of a CuII
complex of an L. patella derived cyclic peptide (the other is
that of [Cu2(H2asc)(1,2-μ-CO3)(H2O)2]·2H2O, determined by
single crystal X-ray crystallography,34 shown in Fig. 9; see also
Fig. 7 for the only other structure of a metal complex of this
type of ligand available a decade ago.124
A new modular synthesis, with improved efficiency and
variability65,68,78 has helped to prepare a range of L. patella
type cyclic pseudo-octapeptides with varying heterocyclic
donor sets and configurations of the macrocycle side chains
(H4pat
1–H4pat
5, see Scheme 2), including ligands with an iden-
tical donor set and/or side-chain configurations as observed in
the natural products.56,57,89
In all complexes of these cyclic pseudo-octapeptides, CuII is
generally coordinated to two heterocyclic nitrogen atoms and a
nitrogen of a deprotonated amide group, forming the usual
Nhet–Namide–Nhet bonding motif. The formation of the mono-
and dinuclear CuII complexes involves a metal-ion assisted
deprotonation (vide supra). Based on electronic absorption, CD
and EPR spectral titrations, the following sequence of com-
plexation reactions with CuII was proposed for patellamide D,
with formation of a carbonato complex, similar to that
observed with the dicopper(II) complex with ascidiacycl-
amide.34,94
½CuðMeOHÞ2þ þ H4patDþ NEt3 ! ½CuðH3patDÞþ þ NEt3Hþ
½CuðH3patDÞþ þ ½CuðMeOHÞ2þ þ NEt3
! ½Cu2ðH2patDÞ2þ þ NEt3Hþ
Fig. 7 X-ray (left) and chemical structure (right) of the potassium(I) complex of hydrolyzed ascidiacyclamide.124
Fig. 8 Solution structure of the dicopper(II) complex of H4patN (MM-EPR; green: Cu, blue: N, red: O, yellow: S, cyan: C).
48 Reprinted with
permission from Inorganic Chemistry from ref. 48. Copyright 1998 by American Chemical Society.
Fig. 9 Top and side view of [Cu2
II(H2asc)(µ-CO3)] (X-ray structure).
34
Reproduced by permission of Wiley-VCH from ref. 57.
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½Cu2ðH2patDÞ2þ þ NEt3 ! ½Cu2ðH2patDÞðOHÞþ þ NEt3Hþ
½Cu2ðH2patDÞðOHÞþ þ CO2 ! ½Cu2ðH2patDÞðCO3Þ þH2O
Extensive studies with the series of the synthetic analogues
H4pat
1–H4pat
5 as well as with patN, patL, patJ1 and patJ2 (see
Scheme 2)48,53,56,57,89 led to the general scheme of solution
equilibria shown in Scheme 4. Note that (i) the preequilibrium
with “outside coordination” of two macrocycles to one CuII
center (see also section on the CuII chemistry of the pseudo-
hexapeptides above) has so far only been observed with
oxazole-based ligands. (ii) There are two isomers of the mono-
hydroxo-dicopper(II) complexes, one with a terminal and one
with a bridging hydroxide. Both have distinct structural pro-
perties (determined in solution by MM-EPR;57 with H4pat
1 we
have been able to trap the hydroxo-bridged complex and solve
the structure by X-ray crystallography.56 (iii) There is one more
species in equilibrium, a “pink species” which never has been
fully characterized – it forms slowly from both the carbonato
and the diaqua complexes upon addition of excess base;53,56,57
for the reactivities discussed below it does however not seem
to be of importance.
3.2.2. Structural properties. Cooperative binding of two
CuII ions to the patellamide-type cyclic pseudo-octapeptides
(see above, see Table 1)48,53,56,57,89,133 was confirmed by com-
putational and experimental structural work to be the result of
a preorganization of the second binding site of the macrocycle
by coordination to the first CuII ion.56,57 For H4pat
2 this is visu-
alized in Fig. 10: the overlay of the computed and experimental
structures of the metal-free ligand shows that the compu-
tational model used is appropriate (this is also confirmed by a
comparison of the experimental and computed structures of
[(H2pat
1)(µ-OH)]+, see below); the overlay of the computed
structures of the metal-free ligand and the mono-copper(II)
complex indicates that significant structural rearrangement is
required while the overlay of the mono- and dinuclear com-
plexes shows that their structures are close to identical.58
The conformational analysis of the metal-free macrocycles
revealed that it is not possible for H4pat
1 to adopt a similar
structure to those of H4asc or H4patD, as the incorporated
dimethyl-imidazole rings introduce severe steric constraints
(see also section on the ligand structures).59 With H4pat
1 and
two equivalents of CuII at low base concentrations a dinuclear
CuII aqua complex is formed [Cu2
II(H2pat
1)(H2O)]
2+.58 Align-
ment of the two CuII centers along the magic angles (θ = 54.7°,
ϕ = 45.0°) eliminates the dipole–dipole contribution to the an-
isotropic exchange interaction, producing an “apparent mono-
nuclear EPR spectrum”. Addition of more than three
equivalents of base leads to the formation of two structurally
different hydroxo complexes, one with a terminal hydroxide,
[Cu2
II(H2pat
1)(OH)]+, the other with a hydroxo bridge,
[Cu2
II(H2pat
1)(µ-OH)]+ (see Scheme 4). In the former complex
the two CuII centers are in a similar orientation to that in the
aqua complex, i.e. along the magic angles, while the formation
of a hydroxo bridge leads to a reorientation of the CuII centers
and the macrocyclic backbone, such that a typical dipole–
dipole coupled EPR spectrum emerges.
As predicted by the simulated EPR spectra, the mono- and
dinuclear CuII complexes of H4pat
1 are found to have a dis-
torted square pyramidal coordination geometry, where the
equatorial donor atoms involve two imidazole nitrogens Nhet,
one amide nitrogen Namide, and one oxygen of a coordinated
water molecule. The apical Cu1–O2 distance is with 2.29 Å as
expected (pseudo-Jahn–Teller distortion) significantly longer
than that in the equatorial plane (Cu1–O1 = 2.04 Å). DFT ana-
lyses of the corresponding ligand conformations suggest that
the ligand in the hydroxo-bridged complex is 25 kJ mol−1 more
stable than the conformation in the mononuclear complex,
and this again explains the preferred formation of dinuclear
complexes (cooperativity, see above).
Comparison of the X-ray structures of H4asc and its dinuc-
lear carbonato-bridged complex with the DFT optimized and
X-ray structures of H4pat
1 and its hydroxo-bridged complex
reveals structural similarities between the two systems but also
important differences (see Fig. 11). Overlay of the structures of
the metal-free macrocycles with those of their dinuclear CuII
complexes illustrates the high degree of preorganization for
the formation of the dinuclear complexes. The significant
differences between the H4asc and H4pat
1 systems are primar-
ily related to the tighter folding of the natural metal-free
macrocycle compared to the imidazole-derived synthetic
ligand, and the resulting differences in the relative orientation
of the two CuII sites (distance and twist of the planes, see also
Fig. 12 and 13 for a comparison of the structures of various
dicopper(II) complexes). From the experimental and computed
structures it emerges that the resulting structure of the ligand
backbone and the two CuII sites in the case of H4asc is well
suited for a bridging carbonate (3-atom bridge, Cu⋯Cu =
4.3 Å), while with H4pat
1 the dinuclear complex is preorganized
for the much smaller hydroxo bridge (1-atom bridge, Cu⋯Cu =
Fig. 10 (a) X-ray structure of H4pat
2; (b) overlay of the X-ray structure
of H4pat
2 (red) with its DFT-optimized structure; (c) overlay of the DFT-
optimized structures of H4pat
2 (red) with its mononuclear CuII complex
(color-coded); (d) overlay of the DFT-optimized structures of the mono-
nuclear CuII complex of H4pat
2 (red) with its dinuclear CuII complex
(color-coded). Reprinted with permission from Inorganic Chemistry
from ref. 56. Copyright 2011 by American Chemical Society.
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3.6 Å). Formation of carbonato-bridged complexes with H4pat
1
could not be observed experimentally so far.56,57 The substi-
tution of the oxazoline and thiazole heterocycles of patell-
amides by dimethyl-imidazoles leads to more rigid macrocycles
that retain most characteristics of the natural systems (see also
section on the structures of the metal-free ligands). In the
solid state and in solution the macrocycle H4pat
1 adopts a con-
formation very close to that of symmetrical patellamides such
as H4asc. Analysis of the X-ray structures in combination with
DFT calculations and spectroscopic investigations showed that
the lower flexibility does not strongly influence the preorgani-
zation of the macrocycle for the formation of dinuclear CuII
complexes, and this also emerges from the corresponding
stability constants (see Table 1).
3.2.3. Reactivities. The formation of carbonato-bridged
dicopper(II) complexes indicated that CO2 hydration might be
a function of the Lissoclinum patella pseudo-octapeptides.
With H4pat
2 a corresponding complex could be trapped, and
its structure was unambiguously determined by EPR spectro-
scopy together with UV-vis-NIR, CD and MS experiments and
combined with DFT-based structure optimization.59 Interest-
ingly, the structure was determined to be strikingly different to
that of [Cu2(H2asc)(1,2-μ-CO3)(H2O)2] (see above and Fig. 12;
note that the carbonate bridge in the H4asc system is in the
equatorial position for both CuII centers with a Cu⋯Cu dis-
tance of 3.6 Å, in the H4pat
2 system the carbonate is bound
equatorially to one and axially to the other CuII center with a
Cu⋯Cu distance of 5.1 Å). It was suggested that a change
between various conformations is important to prevent
product inhibition in a putative catalytic cycle, and that this
depends on the configuration of the macrocycle side-chains
and the flexibility of the heterocycles (oxazoline vs. imidazole);
this was confirmed by preliminary molecular dynamics and
Monte-Carlo simulations.57 Based on 13C and 18O labeling in
combination with ESI-MS and NMR experiments, a plausible
catalytic cycle was proposed (see Scheme 5), however, catalytic
turnover was not shown unambiguously at that stage.57 The
proposed catalytic hydration pathway involves the interaction
of CO2 with one of the Cu
II centers and attack of the OH−
nucleophile at the carbon atom of CO2, leading to a bridging
carbonate at the dinuclear active site. 13C and 18O labeling
experiments support this mechanistic scenario.57
Carbonic anhydrase kinetics are complicated by the fact
that a gas is transformed to an ionisable compound, that
the solubilities of the species involved in various equilibria
strongly depend on solvent, temperature, pressure and pH
value, and that all relevant species are colorless (see
Scheme 6). Generally, carbonic anhydrase kinetics are
measured by stopped-flow techniques, where the time
Fig. 11 Top (left) and side views (right) of the following overlay plots:
(a) H4asc and [Cu2
II (H2asc)(µ-CO3)] (X-ray structures); (b) X-ray structure
of H4pat
1 (black) with its computed (G09, B3LYP/6-31g*/TZVP, tur-
quoise) dinuclear CuII complex [Cu2
II(H2pat
1)(µ-OH)]+ (note that this
structure is very similar to the corresponding X-ray structure, see Fig. 13;
it has been optimized to obtain the relative strain induced to the ligand
at the minimum of the potential energy surface). Reprinted with
permission from Inorganic Chemistry from ref. 56. Copyright 2011 by
American Chemical Society.
Fig. 12 Structures of the dicopper(II) complexes of H4asc, H4pat
1 and
H4pat
2 in top (left) and side views (right); top: [Cu2
II(H2asc)(µ-CO3)],
34
middle: [Cu2
II(H2pat
1)(µ-OH)]+,58 bottom: [Cu2
II(H2pat
2)(µ-CO3)];
56,57 the
top two structures are X-ray and the bottom is an MM-DFT-EPR struc-
ture. Reproduced by permission of Wiley-VCH from ref. 57.
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dependence of the color change of a pH indicator is followed,
using matched pairs of bases (to capture the protons released
from H2CO3, see Scheme 6) and indicators.
90,134 It emerges
that the pH is not constant during the reaction – for the
studies involving the patellamide-type pseudo-octapeptides,
there was a change of approx. two pH units under the con-
ditions of the experiments, and this needs to be considered in
the analysis of the data. The results, based on the six synthetic
pseudo-octapeptides of Scheme 2 and four base/indicator
pairs (pKa values of approx. 6.2, 7.1, 8.1, 8.2) are presented in
Table 2.23,34,43,56,57,90,93,94 It follows that all six patellamide-
based dicopper(II) complexes are very efficient carbonic anhy-
drase catalysts with maximum efficiency using Tris [(tris-
hydroxymethyl)-aminomethane, pKa = 8.07] as base, with a
turnover number (TON) of at least 1700 (limited only by the
amount of base used) and a catalytic rate between 1.7 × 103 and
7.3 × 103 s−1. The rate of the uncatalyzed hydration of CO2 at
25° is 3.7 × 10−2 s−1,134,135 i.e. there is an approx. 105-fold
acceleration by the dicopper(II)–patellamide catalysts, and this
is only approx. 2 orders of magnitude slower than the enzymes
(2 × 105–1.4 × 106 s−1);134,136 rates of other model systems gen-
erally are smaller (1 × 102–5 × 103 s−1, typically in the pH range
of 7–9),137 and the systems discussed here are the most
efficient CO2 hydration catalysts known so far. Very interest-
ingly, the synthetic analogue H4pat
1, where we have not been
able to trap a carbonato-bridged complex, is the most efficient
catalyst studied, more efficient than H4L
ascA, the structurally
most similar model of H4asc.
23,34,43,56,57,90,93,94 This is in
agreement with the mechanistic scenario shown in Scheme 6
and rate-determining nucleophilic attack at the CO2 carbon
atom coordinated to one of the CuII centers by the hydroxo
group coordinated to the other CuII center. It also indicates
that partial inhibition by product (carbonate or bicarbonate)
coordination can decrease the catalytic efficiency, and this
seems to be linked to the configuration of the peptide side-
chains, where the natural (mixed) configuration in H4L
ascA and
H4pat
1 lead, as expected,58 to little inhibition (this is supported
by the fact that so far no carbonato-bridged species was
observed with H4pat
1, see above).
The efficient dicopper(II)-cyclic pseudo-octapeptide cata-
lyzed “hydrolysis” of CO2 indicated that other similar reactions
might be possible, and that of phosphoesters, i.e. phospha-
tase-type activity, seemed to be a reasonable option to test.88
The dicopper(II) complex of H4pat
1 was tested with the usual
substrates [bis(2,4-dinitrophenyl)phosphate, BDNPP, as a
phosphodiester, and 2,4-dinitrophenylphosphate, DNPP, as a
phosphomonoester in H2O : MeCN :MeOH = 50 : 45 : 5 (solubi-
lity); other conditions are given in the caption to Fig. 14].58
Indeed, the patellamide–dicopper(II) complexes are very
efficient phosphatase mimics for phosphodiesters, and the
bell-shaped dependence of the rate from pH indicates that a
mechanism similar to that proposed for purple acid phospha-
tases (PAP) applies, i.e. the phosphoester coordinates to the
copper site with a coordinated H2O and is attacked by the
hydroxide nucleophile coordinated to the other copper center
– this is also consistent with the expected pKa values of H2O
coordinated to the two copper(II) centers and the corres-
ponding observations with the CO2 hydration reactivity, see
above (Scheme 7, Fig. 14).88 An interesting observation is that
[Cu2
II(H2pat
1)(OH)(H2O)]
+ also efficiently catalyzes the hydro-
lysis of the monoester DNPP. Although this is the biological
role of purple acid phosphatases,58 it was only recently that
low molecular weight mimics were first shown to be able to
fulfil this requirement.138,139 In these diiron PAP model
systems, the monoesterase activity was achieved by carefully
designed secondary interactions (H-bonding networks) which
prevented bridging geometries of the monoester and phos-
phate substrates and products. It appears that the confor-
mational flexibility of the patellamide–dicopper systems fulfils
a similar role (see carbonic anhydrase activity discussed above)
but at this moment this is only a speculation which needs to
be substantiated with further studies.
3.3. Possible biological functions
The metabolic role of the cyclic pseudo-peptides is unknown,
even metal ion coordination, specifically that of CuII, which
has been studied in vitro in much detail in recent years, has
not been supported by biochemical studies. Nevertheless, a
number of observations indicate that CuII coordination might
be of importance and CuII storage and transport, CO2 fixation,
Cu2
II transport and phosphatase activity as well as oxygen acti-
vation – specifically if the cyclic peptides should be prosthetic
groups in peptides – have been discussed as possible biologi-
cal functions (note that possible natural roles have primarily
Fig. 13 Top: ORTEP plot of the S* enantiomer of the crystal structure
of the hydroxo-bridged cation [Cu2
II(H2pat
1)(µ-OH)(H2O)2]
+, top (left)
and side view (right). Ellipsoids are drawn at 50% probability, hydrogen
atoms and solvent molecules are omitted for clarity; C = grey, N = blue,
O = red, Cu = yellow. Bottom: schematic representation of the twist of
the binding sites in the hydroxo bridged complex of H4pat
1 (left) and the
carbonato bridged complex of H4asc (right; dimethylimidazole ring:
blue; oxazoline ring: red; thiazole ring: ochre). Reprinted with
permission from Inorganic Chemistry from ref. 56. Copyright 2011 by
American Chemical Society.
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been discussed for the patellamide/ascidiacyclamide-type
pseudo-octapeptides, the corresponding westiellamide-type
pseudo-hexapeptides and the other macrocycles shown in
Scheme 1 have not been considered in detail so
far).34,56–58,88,91,138 It is of interest that recent preliminary
experiments of the corresponding ZnII complexes122 indicate
not unexpectedly that these also are efficient catalyst for phos-
phoester hydrolysis,140 and we anticipate that they will also
show carbonic anhydrase activity. Another set of preliminary
experiments indicates that interesting vanadium chemistry is
to be expected – and this is relevant due to the known affinity
of the ascidians for VIII. It also appears that, apart from CO2
hydration (and its reverse of course) and phosphatase activity,
other biologically relevant hydrolysis reactions might be cata-
lyzed by metal complexes of the cyclic peptides. It is quite
evident that interesting experimental data combined with
theory-based studies will help to complete the current picture
Scheme 5 [CuII(H2pat
n)(OH)]+ catalyzed hydration of CO2: carbonic anhydrase activity. Reproduced from ref. 90.
Scheme 6 Equilibria involved in the hydration of CO2. The catalyst
(Cat) corresponds to the dinuclear [CuII(H2pat
n)(OH)]+ complex. Repro-
duced from ref. 90.
Dalton Transactions Perspective
This journal is © The Royal Society of Chemistry 2014 Dalton Trans., 2014, 43, 1935–1956 | 1951
Pu
bl
ish
ed
 o
n 
30
 O
ct
ob
er
 2
01
3.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f Q
ue
en
sla
nd
 on
 12
/10
/20
15
 02
:38
:30
. 
View Article Online
of the reactivities of natural and synthetic cyclic pseudo-
peptide ligands coordinated to metal ions. However, for an
unambiguous answer to the question, what the biological role
of these interesting natural products is, their biochemistry
needs to be studied.
4. Conclusions
The issues raised in a 1993 review of marine metabolites
and metal ion chelation, i.e. the availability of the cyclic
pseudo-peptides and their metal complexes, an unambiguous
Table 2 Hydration rates of CO2, catalyzed by the dicopper(II) complexes of the six analogues of the patellamides given in Scheme 2,
90 (kcat; reac-
tions with 8.5 mmol base, 17 mmol CO2, 5 μmol catalyst, 12.5 μmol indicator, in a water–methanol 9 : 1 at 25 °C; analysis based on parameters from
the literatur, see ref 90 for details; average and standard deviation of 5 independent measurements)
Ligand
kcat [s
−1]
pKa 6.21 pKa 7.14 pKa 8.07 pKa 8.22
H4pat
1 1.71 × 10−3 ± 9.09 × 10−4 7.08 × 101 ± 2.32 × 100 7.32 × 103 ± 3.65 × 102 6.00 × 102 ± 1.75 × 102
H4pat
2 1.54 × 10−3 ± 1.26 × 10−3 6.96 × 101 ± 1.41 × 100 1.72 × 103 ± 1.05 × 102 1.15 × 102 ± 1.28 × 101
H4pat
3 1.10 × 10−3 ± 9.35 × 10−4 7.32 × 101 ± 6.04 × 100 1.86 × 103 ± 8.00 × 101 1.18 × 102 ± 3.80 × 101
H4pat
4 2.27 × 10−3 ± 1.25 × 10−3 7.74 × 101 ± 1.62 × 101 1.92 × 103 ± 1.10 × 102 1.12 × 102 ± 2.20 × 101
H4pat
5 1.94 × 10−3 ± 1.32 × 10−3 7.25 × 101 ± 2.63 × 100 2.05 × 103 ± 2.91 × 101 1.11 × 102 ± 1.63 × 101
H4L
ascA 1.41 × 10−3 ± 1.14 × 10−3 7.49 × 101 ± 4.55 × 100 4.68 × 103 ± 2.04 × 102 2.59 × 102 ± 2.30 × 101
Fig. 14 pH- and BDNPP concentration dependence of the [CuII2(H2pat
1)(μ-OH)(H2O)2]+-catalyzed BDNPP hydrolysis (error bars are standard devi-
ations obtained from fits of the relevant Michaelis–Menton equations);88 catalyst concentration: 40 µM, BDNPP for the pH dependence: 6.25 mM,
pH for the substrate dependence: 7.06, µ = 0.45; pHmax = 7.21; pKa
I = 6.91 ± 0.21, pKa
II = 7.31 ± 0.20 (in our mechanistic model, these correspond to
the pKa values of the two coordinated OH2 molecules); KM = (26.4 ± 2.20) mM; kcat = (3.95 ± 0.07) × 10
−3 s−1; kcat/KM = 0.15 ± 0.03). Reproduced
from ref. 88.
Scheme 7 [CuII(H2pat
1)(OH)]+ catalyzed phosphoester hydrolysis: phosphatase reactivity.88
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characterization of the relevant structures and the analysis of
possible reactivities of the metal complexes in relation to their
putative biological activities,112 have been addressed with
some success in the last two decades. The syntheses of cyclic
pseudo-peptides, although still time consuming, have been
developed to an extent, where, particularly for the peptides
based on the L. patella families, there now are methods which
allow a relatively large variety of these macrocyclic ligands to
be obtained in respectable yields utilising tedious but efficient
procedures. Their stereochemical and solution structural
assignments have now become routine. The suggestion that mole-
cular mechanics studies should assume greater importance
has proved to be valuable;112 of particular importance, specifi-
cally for the CuII complexes and the relatively complex solution
equilibria in which they are involved, was the combination of
various experimental and theory-based structural and spectro-
scopic approaches – a methodology that has been shown to be
of importance in transition metal coordination chemistry in
general.141 The issue of the relevance of the metal complexes
for the biological activity of the peptides remains largely un-
resolved although recent developments in terms of the carbonic
anhydrase and phosphatase chemistry of the CuII complexes are
providing an interesting and potentially significant advance.
The break-through in our own studies was the accessibility
of a variety of ligands based on a modular synthesis which
allowed the preparation of appreciable quantities of ligands in
relatively short time, and with the possibility to tune their struc-
tures and flexibilities as well as the electronics of the donor
groups via the type of heterocycle and the configuration of the
macrocycle side-chain.54,56,57,65,66,68 The other important
factor, leading to a comprehensive account with respect to the
coordination chemistry involved, is based on the combination
of various spectroscopies (UV-vis-NIR, CD, MCD, ESI-MS,
NMR, EPR, HYSCORE and ENDOR) with computational mod-
eling (structure optimization and electronic structure calcu-
lation); thorough kinetic studies and thermodynamic analyses
have started to appear and begin also to be combined with
modeling approaches – in this area there still is important
work ahead. Obvious next steps are similar sets of experiments
with other metal ions and other (hydrolysis) reactions. Prelimi-
nary experiments indicate that the corresponding ZnII
complexes are also efficient phosphatase models and that
stable vanadium complexes are available.140 Extension of these
experiments might lead to interesting and possibly important
new avenues. However, the important and demanding question
remains: are the observed reactivities (carbonic anhydrase,
phosphatase and others) related to the biological function of
these fascinating natural products?
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